Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

SR-BI receptor implicated in HDL metabolism

June 11, 1997

Eclipse cleared by FDA to begin clinical trials of PTMR

June 10, 1997

Pfizer terminates E5 marketing agreement

June 10, 1997

IVIg for acute cardiomyopathy

June 9, 1997

New C5a antagonist discovered by Rhone-Poulenc Rorer

June 4, 1997

NEP/ACE/ECE inhibitors described by Wakamoto

June 4, 1997

NeoRx reaches milestone in Biostent development

June 4, 1997

Anti E- and P-selectin antibodies from PDL

June 4, 1997

Comparative studies reported for treatment of paroxysmal atrial fibrillation

June 3, 1997

Tanabe Seiyaku reveals new ET antagonists

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...